BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...new investors including the McQuade Center for Strategic Research and Development, Founders Fund, Able Partners, Camden Partners...
BioCentury | May 30, 2019
Emerging Company Profile

Thrive’s quest to bring multicancer liquid biopsy test into routine clinical use

...Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Exact Sciences Corp., Cowin Venture, Camden Partners...
...Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Exact Sciences Corp., Cowin Venture, Camden Partners...
BioCentury | May 6, 2019
Financial News

May 6 Financial Quick Takes: Athenex, Spiral

...included new investors Sunghwan Choi and Inveready. An investor syndicate led by Savoir Capital and Camden Partners...
BioCentury | Jun 22, 2018
Financial News

Qiming leads series B for cancer play WindMIL

...an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners...
BioCentury | Jun 18, 2018
Financial News

Qiming leads series B for cancer play WindMIL

...an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners...
BioCentury | Aug 11, 2016
Financial News

Metabolon raises $15M in series E

...The company declined to comment on its plans for repurchasing shares. Metabolon's prior investors include Camden Partners...
BioCentury | Jan 6, 2014
Company News

Metabolon board of directors update

...Metabolon Inc. , Durham, N.C. Business: Supply/Service, Diagnostic Appointed: Christopher Kersey, managing member at Camden Partners WIR Staff Diagnostic...
BioCentury | Jan 6, 2014
Financial News

Metabolon completes venture financing

...Durham, N.C. Business: Supply/Service, Diagnostic Date completed: 1/3/14 Type: Venture financing Raised: $15 million Investors: Camden Partners...
BioCentury | Jan 4, 2014
Financial News

Metabolon raises $15 million in E round

...Inc. (Durham, N.C.) raised $15 million in a series E round led by new investor Camden Partners...
...investors Aurora Funds; Harris & Harris Group; Syngenta Ventures; Fletcher Spaght; and Fulcrum Financial Partners. Camden Partners'...
BioCentury | Jun 27, 2011
Finance

What to do with $101M

...include Three Arch Capital (19% pre-IPO stake); SightLine Partners (9.3%); Pappas Ventures (7.9%); Invesco (7.9%); Camden Partners...
Items per page:
1 - 10 of 15
BioCentury | Apr 28, 2020
Finance

April 27 Quick Takes: Avalyn raises $35M for fibrosis therapies, plus Actym, LifeSprout, HebeCell, Compass, Immunomic

...new investors including the McQuade Center for Strategic Research and Development, Founders Fund, Able Partners, Camden Partners...
BioCentury | May 30, 2019
Emerging Company Profile

Thrive’s quest to bring multicancer liquid biopsy test into routine clinical use

...Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Exact Sciences Corp., Cowin Venture, Camden Partners...
...Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, The Invus Group, Exact Sciences Corp., Cowin Venture, Camden Partners...
BioCentury | May 6, 2019
Financial News

May 6 Financial Quick Takes: Athenex, Spiral

...included new investors Sunghwan Choi and Inveready. An investor syndicate led by Savoir Capital and Camden Partners...
BioCentury | Jun 22, 2018
Financial News

Qiming leads series B for cancer play WindMIL

...an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners...
BioCentury | Jun 18, 2018
Financial News

Qiming leads series B for cancer play WindMIL

...an untranched series B round led by Qiming Venture Partners. Fellow new investors Medivate Partners, Camden Partners...
BioCentury | Aug 11, 2016
Financial News

Metabolon raises $15M in series E

...The company declined to comment on its plans for repurchasing shares. Metabolon's prior investors include Camden Partners...
BioCentury | Jan 6, 2014
Company News

Metabolon board of directors update

...Metabolon Inc. , Durham, N.C. Business: Supply/Service, Diagnostic Appointed: Christopher Kersey, managing member at Camden Partners WIR Staff Diagnostic...
BioCentury | Jan 6, 2014
Financial News

Metabolon completes venture financing

...Durham, N.C. Business: Supply/Service, Diagnostic Date completed: 1/3/14 Type: Venture financing Raised: $15 million Investors: Camden Partners...
BioCentury | Jan 4, 2014
Financial News

Metabolon raises $15 million in E round

...Inc. (Durham, N.C.) raised $15 million in a series E round led by new investor Camden Partners...
...investors Aurora Funds; Harris & Harris Group; Syngenta Ventures; Fletcher Spaght; and Fulcrum Financial Partners. Camden Partners'...
BioCentury | Jun 27, 2011
Finance

What to do with $101M

...include Three Arch Capital (19% pre-IPO stake); SightLine Partners (9.3%); Pappas Ventures (7.9%); Invesco (7.9%); Camden Partners...
Items per page:
1 - 10 of 15